Wound-Healing Promotion and Anti-Inflammatory Properties of Carvacrol Prodrugs/Hyaluronic Acid Formulations

Background. Wound healing (WH) is a complex process involving several stages, such as hemostasis, inflammation, re-epithelialization, and remodeling. Many factors can impair WH, and different pharmacological approaches were studied to date, but the increase in antibiotic resistance, invasiveness, tr...

Full description

Bibliographic Details
Main Authors: Lisa Marinelli, Ivana Cacciatore, Erica Costantini, Marilisa Pia Dimmito, Federica Serra, Antonio Di Stefano, Marcella Reale
Format: Article
Language:English
Published: MDPI AG 2022-07-01
Series:Pharmaceutics
Subjects:
Online Access:https://www.mdpi.com/1999-4923/14/7/1468
_version_ 1797444361490792448
author Lisa Marinelli
Ivana Cacciatore
Erica Costantini
Marilisa Pia Dimmito
Federica Serra
Antonio Di Stefano
Marcella Reale
author_facet Lisa Marinelli
Ivana Cacciatore
Erica Costantini
Marilisa Pia Dimmito
Federica Serra
Antonio Di Stefano
Marcella Reale
author_sort Lisa Marinelli
collection DOAJ
description Background. Wound healing (WH) is a complex process involving several stages, such as hemostasis, inflammation, re-epithelialization, and remodeling. Many factors can impair WH, and different pharmacological approaches were studied to date, but the increase in antibiotic resistance, invasiveness, treatment duration, and high cost, have often hampered the resolution of the wound. In this study, we investigated the possible application of water-soluble carvacrol prodrugs (WSCPs) and hyaluronic acid (HA) and their formulations (WSCPs/HA) to improve WH and regulate the inflammatory response. Materials and methods. Firstly, the cytotoxicity of 0.1, 1 and 10 µg/mL of HA, WSCPs and WSCPs/HA formulations were evaluated on HaCaT cells and THP-1 cell lines. The ability of WSCPs/HA formulations to modulate wound repair was evaluated in an in vitro model of WH, using HaCaT cells at 6, 18, and 24 h. The expression of WH mediators, after wound closure was determined by qRT-PCR. Following, we polarized THP-1 cells in M1/M2-like macrophages and tested the anti-inflammatory properties of WSCPs/HA formulations. After, we tested the in vitro WH model for the effects of conditioned medium (CM) from M1/M2-like cells cultured in the presence of WSCPs/HA. Results. Results showed that WSCPs/HA formulations were able to significantly raise the wound closure rate, compared to the single constituents, promoting a complete wound closure after 18 h for WSCP1/HA (10 µg/mL) and after 24 h for WSCP2/HA (10 µg/mL), modulating the MMPs, TGFβ, and COX-2 gene expression. The effects of CM derived from M1/M2 polarized cells cultured in the presence of WSCPs/HA determined WH regulation, with a better ability of the WSCP2/HA formulation to modulate the time-dependent expression of reparative and inflammatory mediators. Conclusion. Our data underline the possible application of WSCPs/HA formulations as bioactive agents for the regulation of the wound repair process by the modulation of inflammatory and remodeling phases, affecting the activity of immune cells.
first_indexed 2024-03-09T13:10:35Z
format Article
id doaj.art-5f6321b5f6324fb7960f6bd85fac7e81
institution Directory Open Access Journal
issn 1999-4923
language English
last_indexed 2024-03-09T13:10:35Z
publishDate 2022-07-01
publisher MDPI AG
record_format Article
series Pharmaceutics
spelling doaj.art-5f6321b5f6324fb7960f6bd85fac7e812023-11-30T21:42:16ZengMDPI AGPharmaceutics1999-49232022-07-01147146810.3390/pharmaceutics14071468Wound-Healing Promotion and Anti-Inflammatory Properties of Carvacrol Prodrugs/Hyaluronic Acid FormulationsLisa Marinelli0Ivana Cacciatore1Erica Costantini2Marilisa Pia Dimmito3Federica Serra4Antonio Di Stefano5Marcella Reale6Department of Pharmacy, “G. d’Annunzio” University of Chieti-Pescara, 66100 Chieti, ItalyDepartment of Pharmacy, “G. d’Annunzio” University of Chieti-Pescara, 66100 Chieti, ItalyDepartment of Medicine and Science of Aging, “G. d’Annunzio” University of Chieti-Pescara, 66100 Chieti, ItalyDepartment of Pharmacy, “G. d’Annunzio” University of Chieti-Pescara, 66100 Chieti, ItalyDepartment of Pharmacy, “G. d’Annunzio” University of Chieti-Pescara, 66100 Chieti, ItalyDepartment of Pharmacy, “G. d’Annunzio” University of Chieti-Pescara, 66100 Chieti, ItalyDepartment of Innovative Technologies in Medicine and Dentistry, “G. d’Annunzio” University of Chieti-Pescara, 66100 Chieti, ItalyBackground. Wound healing (WH) is a complex process involving several stages, such as hemostasis, inflammation, re-epithelialization, and remodeling. Many factors can impair WH, and different pharmacological approaches were studied to date, but the increase in antibiotic resistance, invasiveness, treatment duration, and high cost, have often hampered the resolution of the wound. In this study, we investigated the possible application of water-soluble carvacrol prodrugs (WSCPs) and hyaluronic acid (HA) and their formulations (WSCPs/HA) to improve WH and regulate the inflammatory response. Materials and methods. Firstly, the cytotoxicity of 0.1, 1 and 10 µg/mL of HA, WSCPs and WSCPs/HA formulations were evaluated on HaCaT cells and THP-1 cell lines. The ability of WSCPs/HA formulations to modulate wound repair was evaluated in an in vitro model of WH, using HaCaT cells at 6, 18, and 24 h. The expression of WH mediators, after wound closure was determined by qRT-PCR. Following, we polarized THP-1 cells in M1/M2-like macrophages and tested the anti-inflammatory properties of WSCPs/HA formulations. After, we tested the in vitro WH model for the effects of conditioned medium (CM) from M1/M2-like cells cultured in the presence of WSCPs/HA. Results. Results showed that WSCPs/HA formulations were able to significantly raise the wound closure rate, compared to the single constituents, promoting a complete wound closure after 18 h for WSCP1/HA (10 µg/mL) and after 24 h for WSCP2/HA (10 µg/mL), modulating the MMPs, TGFβ, and COX-2 gene expression. The effects of CM derived from M1/M2 polarized cells cultured in the presence of WSCPs/HA determined WH regulation, with a better ability of the WSCP2/HA formulation to modulate the time-dependent expression of reparative and inflammatory mediators. Conclusion. Our data underline the possible application of WSCPs/HA formulations as bioactive agents for the regulation of the wound repair process by the modulation of inflammatory and remodeling phases, affecting the activity of immune cells.https://www.mdpi.com/1999-4923/14/7/1468antimicrobialscarvacrol prodrugshyaluronic acid formulationswound healing
spellingShingle Lisa Marinelli
Ivana Cacciatore
Erica Costantini
Marilisa Pia Dimmito
Federica Serra
Antonio Di Stefano
Marcella Reale
Wound-Healing Promotion and Anti-Inflammatory Properties of Carvacrol Prodrugs/Hyaluronic Acid Formulations
Pharmaceutics
antimicrobials
carvacrol prodrugs
hyaluronic acid formulations
wound healing
title Wound-Healing Promotion and Anti-Inflammatory Properties of Carvacrol Prodrugs/Hyaluronic Acid Formulations
title_full Wound-Healing Promotion and Anti-Inflammatory Properties of Carvacrol Prodrugs/Hyaluronic Acid Formulations
title_fullStr Wound-Healing Promotion and Anti-Inflammatory Properties of Carvacrol Prodrugs/Hyaluronic Acid Formulations
title_full_unstemmed Wound-Healing Promotion and Anti-Inflammatory Properties of Carvacrol Prodrugs/Hyaluronic Acid Formulations
title_short Wound-Healing Promotion and Anti-Inflammatory Properties of Carvacrol Prodrugs/Hyaluronic Acid Formulations
title_sort wound healing promotion and anti inflammatory properties of carvacrol prodrugs hyaluronic acid formulations
topic antimicrobials
carvacrol prodrugs
hyaluronic acid formulations
wound healing
url https://www.mdpi.com/1999-4923/14/7/1468
work_keys_str_mv AT lisamarinelli woundhealingpromotionandantiinflammatorypropertiesofcarvacrolprodrugshyaluronicacidformulations
AT ivanacacciatore woundhealingpromotionandantiinflammatorypropertiesofcarvacrolprodrugshyaluronicacidformulations
AT ericacostantini woundhealingpromotionandantiinflammatorypropertiesofcarvacrolprodrugshyaluronicacidformulations
AT marilisapiadimmito woundhealingpromotionandantiinflammatorypropertiesofcarvacrolprodrugshyaluronicacidformulations
AT federicaserra woundhealingpromotionandantiinflammatorypropertiesofcarvacrolprodrugshyaluronicacidformulations
AT antoniodistefano woundhealingpromotionandantiinflammatorypropertiesofcarvacrolprodrugshyaluronicacidformulations
AT marcellareale woundhealingpromotionandantiinflammatorypropertiesofcarvacrolprodrugshyaluronicacidformulations